Recent Finacing
Recent Raise
Cellphire develops platelet-based stabilized therapeutics, including freeze-dried Thrombosomes with multi-year shelf stability and cryopreserved platelets, conducting Phase 2 trials for hemorrhage control, transfusion support, and targeted delivery.